Apexbio Laboratories manufactures the apexbio reagents distributed by Genprice. The Apexbio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio. Other Apexbio products are available in stock. Specificity: Apexbio Category:
Amyloid Precursor C-Terminal Peptide | |||
| A1004-10 | ApexBio | 10 mg | EUR 369 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. | |||
Amyloid Precursor C-Terminal Peptide | |||
| A1004-25 | ApexBio | 25 mg | EUR 496 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. | |||
Amyloid Precursor C-Terminal Peptide | |||
| A1004-5 | ApexBio | 5 mg | EUR 241 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. | |||
Beta-Sheet Breaker Peptide iA?5 | |||
| A1005-10 | ApexBio | 10 mg | EUR 137 |
Description: Beta-Sheet Breaker Peptide iA?5 (C33H43N5O8), with the sequence H-Leu-Pro-Phe-Phe-Asp-OH, has been shown to inhibit amyloidogenesis in rat brain models. | |||
Beta-Sheet Breaker Peptide iA?5 | |||
| A1005-25 | ApexBio | 25 mg | EUR 171 |
Description: Beta-Sheet Breaker Peptide iA?5 (C33H43N5O8), with the sequence H-Leu-Pro-Phe-Phe-Asp-OH, has been shown to inhibit amyloidogenesis in rat brain models. | |||
Beta-Sheet Breaker Peptide iA?5 | |||
| A1005-5 | ApexBio | 5 mg | EUR 102 |
Description: Beta-Sheet Breaker Peptide iA?5 (C33H43N5O8), with the sequence H-Leu-Pro-Phe-Phe-Asp-OH, has been shown to inhibit amyloidogenesis in rat brain models. | |||
Angiotensin I (human, mouse, rat) | |||
| A1006-10 | ApexBio | 10 mg | EUR 166 |
Description: Angiotensin I (Ang I) (C62H89N17O14), with the sequence H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH, is formed by the action of renin on angiotensinogen. | |||
Angiotensin I (human, mouse, rat) | |||
| A1006-25 | ApexBio | 25 mg | EUR 212 |
Description: Angiotensin I (Ang I) (C62H89N17O14), with the sequence H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH, is formed by the action of renin on angiotensinogen. | |||
Angiotensin I (human, mouse, rat) | |||
| A1006-5 | ApexBio | 5 mg | EUR 119 |
Description: Angiotensin I (Ang I) (C62H89N17O14), with the sequence H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH, is formed by the action of renin on angiotensinogen. | |||
Angiotensin 1/2 (1-9) | |||
| A1007-10 | ApexBio | 10 mg | EUR 166 |
Description: Angiotensin I/II (1-9) is a peptide (ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS) containing the amino acids 1-9 that are converted from Angiotensin I/II peptide. | |||
Angiotensin 1/2 (1-9) | |||
| A1007-25 | ApexBio | 25 mg | EUR 212 |
Description: Angiotensin I/II (1-9) is a peptide (ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS) containing the amino acids 1-9 that are converted from Angiotensin I/II peptide. | |||
Angiotensin 1/2 (1-9) | |||
| A1007-5 | ApexBio | 5 mg | EUR 119 |
Description: Angiotensin I/II (1-9) is a peptide (ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS) containing the amino acids 1-9 that are converted from Angiotensin I/II peptide. | |||
Anti-Inflammatory Peptide 1 | |||
| A1008-10 | ApexBio | 10 mg | EUR 166 |
Description: Anti-Inflammatory Peptide 1 (C45H82N12O14S2), with the sequence H-Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser-OH, belongs to the group of synthetic oligopeptides corresponding to a region of high amino-acid sequence similarity between uteroglobin and lipocortin I | |||
Anti-Inflammatory Peptide 1 | |||
| A1008-25 | ApexBio | 25 mg | EUR 212 |
Description: Anti-Inflammatory Peptide 1 (C45H82N12O14S2), with the sequence H-Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser-OH, belongs to the group of synthetic oligopeptides corresponding to a region of high amino-acid sequence similarity between uteroglobin and lipocortin I | |||
Anti-Inflammatory Peptide 1 | |||
| A1008-5 | ApexBio | 5 mg | EUR 119 |
Description: Anti-Inflammatory Peptide 1 (C45H82N12O14S2), with the sequence H-Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser-OH, belongs to the group of synthetic oligopeptides corresponding to a region of high amino-acid sequence similarity between uteroglobin and lipocortin I | |||
ANP (1-11), rat | |||
| A1009-1 | ApexBio | 1 mg | EUR 84 |
Description: Atrial Natriuretic Peptide (ANP) (C49H84N20O15S) has the sequence of H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH, is a 28 amino acid peptide that is synthesized, stored, and released by atrial myocytes in response to atrial distension, endothelin, and sympathetic stimulation. | |||
ANP (1-11), rat | |||
| A1009-10 | ApexBio | 10 mg | EUR 224 |
Description: Atrial Natriuretic Peptide (ANP) (C49H84N20O15S) has the sequence of H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH, is a 28 amino acid peptide that is synthesized, stored, and released by atrial myocytes in response to atrial distension, endothelin, and sympathetic stimulation. | |||